🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2025-524256-64-00
Authorised Phase IV

The impact of extra-fine inhalation corticosteroid particles on small-airway disease in Chronic Obstructive Pulmonary Disease (COPD): a randomized, prospective cross-over trial.

2025-524256-64-00 · tracked via the Priya Life Science EU tracker
Sponsor
CHU Saint Pierre
Sponsor type
Hospital/Clinic/Other health care facility
Therapeutic area
Respiratory Tract Diseases
Decision date
19/01/2026
Enrollment target
60
Sites
Belgium

Condition studied

Chronic Obstructive Pulmonary Disease

Eligibility

Age group
65+ years, 18-64 years
Sex
Female, Male
Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2025-524256-64-00 on CTIS ↗ ← All trials in the EU